| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $8.2M | +101.6% |
| SG&A Expense | $4.3M | +8.5% |
| Operating Income | -$12.5M | -55.6% |
| Income Tax | $0 | — |
| Net Income | -$12.3M | -57.6% |
| EPS (Basic) | -$8.03 | -200.7% |
| EPS (Diluted) | -$8.03 | +79.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Total Assets | $3.5M | -55.7% |
| Total Liabilities | $2.0M | +21.5% |
| Stockholders' Equity | $1.6M | -75.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.2M | -74.2% |
| Financing Cash Flow | $6.9M | -9.5% |